With no revenue in any of the ten quarters through 2026Q3, QuantumScape's operating loss narrowed 31% to $92.4M as SG&A dropped to $18.5M, though R&D still averaged roughly $81M per quarter and dominates about four-fifths of operating spend.
QuantumScape Corporation (QS) annual income statement — 8-year revenue, gross profit & net income history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 |
|---|
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 43.54M | 73.22M | 57.78M | 41.96M | 36.12M | 14.7M | 8.08M | 6.74M | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - |
| Gross Profit | -43.54M | -73.22M | -57.78M | -41.96M | -36.12M | -14.7M | -8.08M | -6.74M | 0 |
| Gross Margin % | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | -26.72% | -37.71% | -16.15% | -145.75% | -81.92% | -19.95% | - | - |
| Operating Expenses | 374.64M | 399.38M | 454.08M | 415.54M | 384.5M | 200.57M | 72.94M | 49.08M | 45.45M |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 75.04M | 97M | 142.24M | 131.09M | 115.34M | 60.28M | 14.69M | 8.71M | 9.27M |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - |
| Research & Development | 327.75M | 375.61M | 311.84M | 284.46M | 269.15M | 140.29M | 58.25M | 40.37M | 35.63M |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | -2M | -73.22M | 0 | 0 | 0 | 0 | 0 | 0 | 551K |
| Operating Income | -418.18M | -472.6M | -511.86M | -457.5M | -420.62M | -215.27M | -81.02M | -55.82M | -45.45M |
| Operating Margin % | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | - | 7.67% | -11.88% | -8.77% | -95.39% | -165.69% | -45.15% | -22.8% | - |
| EBITDA | -361.99M | -399.38M | -446.07M | -407.75M | -384.5M | -200.57M | -72.94M | -49.95M | -39.77M |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | 12.78% | 10.47% | -9.4% | -6.05% | -91.7% | -174.97% | -46.01% | -25.6% | - |
| D&A (Non-Cash Add-back) | 56.19M | 73.22M | 65.79M | 49.75M | 36.12M | 14.7M | 8.08M | 5.86M | 5.68M |
| EBIT | -389.83M | -431.47M | -475.72M | -442.7M | -409.5M | -44.56M | -1.66B | -51.26M | -42.45M |
| Net Interest Income | 33.35M | 36.59M | 43.8M | 34.11M | 8.51M | 464K | -19.67M | 3.51M | 607K |
| Interest Income | 35.24M | 38.63M | 46.02M | 36.49M | 10.9M | 1.88M | 1.09M | 3.61M | 607K |
| Interest Expense | 1.89M | 2.04M | 2.22M | 2.38M | 2.4M | 1.42M | 20.77M | 94K | 0 |
| Other Income/Expense | 35.2M | 39.1M | 33.92M | 12.42M | 8.72M | 169.29M | -1.6B | 4.55M | 1.31M |
| Pretax Income | -382.98M | -433.51M | -477.94M | -445.08M | -411.9M | -45.98M | -1.68B | -51.26M | -44.14M |
| Pretax Margin % | - | - | - | - | - | - | - | - | - |
| Income Tax | 645K | 1.54M | 0 | 0 | 0 | 0 | 0 | 0 | 5K |
| Effective Tax Rate % | -0.17% | -0.36% | 0% | 0% | 0% | 0% | 0% | 0% | -0.01% |
| Net Income | -383.62M | -435.05M | -477.86M | -445.14M | -411.91M | -45.97M | -1.68B | -51.28M | -44.15M |
| Net Margin % | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | 14.68% | 8.96% | -7.35% | -8.07% | -796.11% | 97.27% | -3179.4% | -16.16% | - |
| Net Income (Continuing) | -383.62M | -435.05M | -477.94M | -445.08M | -411.9M | -45.98M | -1.68B | -51.26M | -44.15M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 1.77M | 1.7M | 1.69M | 1.7M | 1.71M | 1.69M |
| EPS (Diluted) | -0.62 | -0.76 | -0.94 | -0.96 | -0.95 | -0.52 | -6.67 | -0.21 | -3.97 |
| EPS Growth % | 23.17% | 19.15% | 2.08% | -1.05% | -82.69% | 92.2% | -3076.19% | 94.71% | - |
| EPS (Basic) | - | -0.76 | -0.94 | -0.96 | -0.95 | -0.12 | -6.67 | -0.21 | -3.97 |
| Diluted Shares Outstanding | 620.56M | 575.95M | 508.1M | 462.24M | 432.97M | 409.51M | 252.14M | 239.64M | 11.11M |
| Basic Shares Outstanding | 620.56M | 575.95M | 508.1M | 462.24M | 432.97M | 404.26M | 252.14M | 239.64M | 11.11M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - |
Quick answers to the most common questions about buying QS stock.
For fiscal year 2025, QuantumScape Corporation (QS) reported total revenue of $0.0M.
QuantumScape Corporation (QS) reported a net loss of $435.1M for the fiscal year ending 2025.
Key Metrics
Top Statement Risk
Limited cash runway before dilutive financing
Metrics are mathematically derived from official filings.
Pre-Revenue Drag Versus Peers
QuantumScape reports zero revenue across all ten quarters through 2026Q3, while pre-commercial peers SES AI and Solid Power each generated roughly $21M in annual revenue per market data, suggesting QS's commercialization lag extends beyond even direct solid-state rivals.
The absence of any revenue line means the Volkswagen PowerCo licensing agreement disclosed in recent filings has not yet translated into recognizable income, so the equity story still rests on technical milestones rather than financial ones. Investors should treat the reported EPS loss trajectory, narrowing from -$0.25 to -$0.14, as a cost-management signal rather than evidence of commercial traction, since no organic or inorganic top line exists to underwrite durability.
Loss Reduction Via Cost Discipline
Operating losses have contracted approximately 31%, from $134.5M in 2024Q2 to $92.4M in 2026Q3, driven not by revenue scaling but by SG&A roughly halving while quarterly R&D held near the $74M-$87M range as per QuantumScape's reported statements.
This is cost discipline rather than operating leverage in the traditional sense; with no gross profit base, the improvement reflects overhead trims and lower stock-based compensation rather than incremental margin on incremental sales. The durability of this trend is questionable if commercialization requires re-hiring and re-investment, which could reverse the SG&A decline before any revenue arrives.
Non-Operating Cushion on Losses
Net losses have consistently printed above operating losses, with 2026Q3 showing an $84.5M net loss against a $92.4M operating loss, and stock-based compensation fell 66%, from $47.8M in 2024Q2 to $16.3M in the latest quarter based on reported figures.
The persistent gap between operating and net loss suggests non-operating income, likely interest on cash and marketable securities, is offsetting a portion of operating burn, which flatters the bottom line without any operating improvement. The sharp decline in SBC materially improves reported EPS optics, but analysts should weigh whether reduced equity grants reflect genuine efficiency or simply lower-valued stock being issued, since dilution economics persist regardless of the expense line.
R&D Dominates Fixed Cost Base
Research and development remains QuantumScape's dominant expense, averaging roughly $81M per quarter and constituting approximately four-fifths of total operating spend, while SG&A declined from $36.7M in 2024Q2 to $18.5M in 2026Q3 as disclosed in company filings.
The flat-to-declining R&D spend despite ongoing Cobra manufacturing process development suggests management is prioritizing selective, higher-return research programs rather than broad experimentation, which may indicate maturation of the technical roadmap or, alternatively, constrained budget flexibility. The volatile SG&A line, including an anomalous $8.3M print in 2025Q4 versus $22-25M in adjacent quarters, warrants scrutiny, as inconsistent classification between development-stage COGS (running $13-20M per quarter with no revenue) and operating expense can obscure true cost discipline.
Runway Risk Outweighs Cost Progress
With approximately $230M in cash against quarterly operating losses near $92M, QuantumScape's implied liquidity runway appears to extend only a handful of quarters, suggesting a material probability of dilutive equity issuance well before commercial-scale production is achieved per recent disclosures.
A short-seller would argue that the loss-narrowing narrative masks a more fundamental problem: the company is burning capital faster than it is generating technical de-risking that the market can price, especially as EV demand softness may push OEM solid-state adoption timelines further out. The counter-consideration is that the PowerCo licensing structure could reduce future capital intensity, shifting the model toward higher-margin, lower-burn economics; however, this remains unproven in reported financials, and investors should monitor whether SG&A and R&D declines reflect strategic focus or underinvestment that imperils the very milestones underpinning the valuation.